For the quarter ending 2026-03-31, DH had -$5,533K decrease in cash & cash equivalents over the period. $8,362K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 55,929 | 61,534 | 179,987 | - |
| Total cost of revenue | 14,279 | 14,625 | 43,621 | - |
| Sales and marketing | 19,578 | 20,135 | 61,502 | - |
| Product development | 6,499 | 9,954 | 24,822 | - |
| General and administrative | 12,084 | 14,321 | 37,306 | - |
| Other segment items, net | -199,278 | -19,699 | -204,792 | - |
| Benefit from income taxes | -3,435 | -53 | -9,906 | - |
| Net loss | -192,354 | -17,147 | -182,150 | - |
| Depreciation and amortization | 1,004 | 991 | 2,312 | - |
| Amortization of intangible assets | 12,245 | 12,904 | 39,903 | - |
| Amortization of deferred contract costs | 3,740 | 3,940 | 11,931 | - |
| Equity-based compensation | 5,220 | 8,161 | 20,983 | - |
| Amortization of debt issuance costs | 159 | 139 | 380 | - |
| Write-off of deferred offering costs | - | 0 | 467 | - |
| Benefit from doubtful accounts receivable | -208 | 403 | -635 | - |
| Loss on partial extinguishment of debt | 0 | 0 | -507 | - |
| Non-cash restructuring charges | 0 | 243 | 352 | - |
| Goodwill impairment charges | 197,219 | 19,533 | 176,531 | - |
| Tax receivable agreement remeasurement | 6,521 | 11,083 | 10,623 | - |
| Changes in fair value of contingent consideration | 0 | 0 | -3,970 | - |
| Deferred income taxes | 3,537 | 568 | 10,310 | - |
| Accounts receivable | -13,259 | 17,967 | -19,351 | - |
| Prepaid expenses and other assets | 4,022 | -1,232 | 3,481 | - |
| Deferred contract costs | -2,868 | -3,976 | -9,376 | - |
| Contingent consideration | - | 0 | 0 | - |
| Accounts payable, accrued expenses and other liabilities | -11,573 | -1,441 | 353 | - |
| Deferred revenue | -199 | 7,356 | -1,468 | - |
| Net cash provided by operating activities | 11,564 | 2,720 | 15,687 | 35,370 |
| Purchases of property, equipment, and data assets | 3,202 | 4,440 | 2,281 | 9,999 |
| Cash paid for acquisitions and investments, net of cash acquired | - | 0 | 0 | 0 |
| Purchases of short-term investments | 12,500 | 0 | 0 | 64,065 |
| Maturities of short-term investments | -9,481 | -60,791 | -26,422 | -147,447 |
| Net cash (used in) provided by investing activities | -6,221 | 56,351 | 24,141 | 73,383 |
| Repayments of term loan | 2,188 | 2,188 | 2,187 | 248,438 |
| Proceeds from term loan | 0 | 0 | 0 | 175,000 |
| Payments of debt issuance costs | 0 | 0 | 0 | 1,660 |
| Taxes paid related to net share settlement of equity awards | 926 | 1,402 | 1,063 | 2,483 |
| Repurchases of class a common stock | 0 | 0 | 9,221 | 40,231 |
| Payments of contingent consideration | - | 0 | 0 | 0 |
| Payments under tax receivable agreement | 7,762 | 0 | 0 | 13,767 |
| Payments of equity offering issuance costs | - | 0 | - | - |
| Member distributions | - | 321 | 0 | 2,827 |
| Net cash used in financing activities | -10,876 | -3,911 | -12,471 | -134,406 |
| Net decrease in cash and cash equivalents | -5,533 | 55,160 | 27,357 | -25,653 |
| Effect of exchange rate changes on cash | - | - | 1,235 | - |
| Cash and cash equivalents, beginning of period | 108,317 | - | 105,378 | - |
| Cash and cash equivalents, end of period | 157,648 | - | 108,317 | - |
Definitive Healthcare Corp. (DH)
Definitive Healthcare Corp. (DH)